Nucleic acid molecules encoding DNA modifying enzymes and active fragments and variants thereof and compositions comprising the same
Compositions and methods comprising novel deaminase polypeptides for targeted editing of nucleic acids are provided. Compositions comprise deaminase polypeptides. Also provided are fusion proteins comprising a DNA-binding polypeptide and a deaminase of the invention. The fusion proteins include RNA-guided nucleases fused to deaminases, optionally in complex with guide RNAs. Compositions also include nucleic acid molecules encoding the deaminases or the fusion proteins. Vectors and host cells comprising the nucleic acid molecules encoding the deaminases or the fusion proteins are also provided.
1. A nucleic acid molecule comprising a polynucleotide encoding a deaminase polypeptide, wherein the deaminase polypeptide has adenine deaminase activity and is encoded by a nucleotide sequence that
a) has at least 90% sequence identity to SEQ ID NO: 451, and
b) encodes an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 407,
wherein said nucleic acid molecule further comprises a heterologous promoter operably linked to said polynucleotide.
2. The nucleic acid molecule of claim 1 , wherein said nucleotide sequence encoding said deaminase polypeptide
a) has at least 95% sequence identity to SEQ ID NO: 451, and
b) encodes an amino acid sequence having at least 95% sequence identity to SEQ ID NO: 407.
3. A nucleic acid molecule comprising a polynucleotide encoding a deaminase polypeptide, wherein said deaminase polypeptide has adenine deaminase activity and is encoded by a nucleotide sequence that
a) has the sequence of SEQ ID NO: 451, or
b) encodes the amino acid sequence of SEQ ID NO: 407.
4. A vector comprising the nucleic acid molecule of claim 1 .
5. The vector of claim 4 , further comprising at least one nucleotide sequence encoding a guide RNA capable of hybridizing to a target nucleic acid.
6. A nucleic acid molecule comprising a polynucleotide encoding a fusion protein, wherein said fusion protein comprises:
a Type II CRISPR-Cas protein nickase and a deaminase,
wherein said deaminase has adenine deaminase activity and comprises an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 407, and wherein said nickase
(a) is a Cas9 nickase; or
(b) comprises an amino acid sequence having at least 95% sequence identity to any one of SEQ ID NO: 42, 52, 53, 55-59, 61, 397, or 398.
7. The nucleic acid molecule of claim 6 , wherein said deaminase comprises an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO: 407.
8. The nucleic acid molecule of claim 6 , wherein said deaminase comprises the amino acid sequence of SEQ ID NO: 407.
9. The nucleic acid molecule of claim 6 , wherein the nickase has the amino acid sequence of any one of SEQ ID NO: 42, 52, 53, 55-59, 61, 397, or 398.
10. The nucleic acid molecule of claim 6 , wherein the polynucleotide encoding the fusion protein is operably linked at its 5′ end to a heterologous promoter.
11. The nucleic acid molecule of claim 6 , wherein the polynucleotide encoding the fusion protein is operably linked at its 3′ end to a heterologous terminator.
12. The nucleic acid molecule of claim 6 , wherein the fusion protein comprises one or more nuclear localization signals.
13. The nucleic acid molecule of claim 6 , wherein the polynucleotide encoding the fusion protein is codon optimized for expression in a eukaryotic cell.
14. The nucleic acid molecule of claim 6 , wherein the polynucleotide encoding the fusion protein is an mRNA.
15. The nucleic acid molecule of claim 6 , wherein said fusion protein comprises the amino acid sequence of SEQ ID NO: 496.
16. A system for modifying a target DNA molecule, said system comprising:
a) the nucleic acid molecule of claim 6 ; and
b) one or more guide RNAs (gRNAs) capable of hybridizing to said target DNA molecule or one or more nucleic acids encoding the one or more gRNAs; and
wherein the one or more gRNAs are capable of forming a complex with the fusion protein in order to direct said fusion protein to bind to said target DNA molecule and modify the target DNA molecule.
17. The system of claim 16 , wherein at least one of said one or more nucleic acids encoding the one or more gRNAs is operably linked to a promoter.
18. The system of claim 16 , wherein the system comprises a vector comprising the nucleic acid molecule of claim 6 and the one or more nucleic acids encoding the one or more gRNAs.
19. The system of claim 16 , wherein the target DNA molecule is within a cell.
20. The system of claim 19 , wherein the cell is a eukaryotic cell.
21. A vector comprising the nucleic acid molecule of claim 3 .
22. The vector of claim 21 , further comprising at least one nucleotide sequence encoding a guide RNA capable of hybridizing to a target nucleic acid.